MRF Blog

Near Life Experiences

October 25, 2017 | Categories: Ocular Melanoma, Patient Stories

Ocular melanoma survivor and 2017 MRF Courage Award recipient Aaron Davis on the importance of "near life experiences."

The MRF Welcomes CEO Elly Brtva

September 29, 2017 | Categories: News

The Board of Directors of the Melanoma Research Foundation (MRF) is excited to announce that Eleanor (Elly) Brtva will assume the role of CEO of the Melanoma Research Foundation, effective immediately. Elly brings a wealth of knowledge, experience and dedication to the MRF and we are eager to welcome her to the organization.

Congress Must Protect DoD Medical Research Funding

September 26, 2017 | Categories: News, Policy, Research

Since 1992, the Department of Defense Congressionally-Directed Medical Research Program (CDMRP) has transformed healthcare for service members and the American public through innovative and impactful biomedical research. As of 2017, Congress has, on a bipartisan basis, provided the CDMRP with $11.9 billion in funding to support high impact, high risk, and high gain projects that other agencies and private investors may be unwilling to fund.

Apply for the Medical Student Research Award

September 1, 2017 | Categories: News, Research

The Melanoma Reserach Foundation (MRF) is now accepting applications for the 2018 Medical Student Research Award. The MRF has been awarding this research grant since 2011 and in this time 35 grants have been awarded to students at 24 different institutions. The purpose of the Medical Student Research Award is to promote scientific inquiry and research opportunities to medical students early in their careers by funding concise clinical or laboratory-based research projects focused on better understanding the prevention, biology, and treatment of melanoma.

What's Next: 

FDA Expands Approval of Ipilimumab For Pediatric Melanoma Patients

August 3, 2017 | Categories: News, Research, Treatment

Last week the United States Food and Drug Administration (FDA) expanded approval of Yervoy (ipilimumab) to include pediatric patients ages 12 years and older with unresectable or metastatic melanoma. Yervoy, a monoclonal antibody that activates the immune system by blocking the CTLA-4 receptor, was first approved in 2011 to treat unresectable or metastatic melanoma in adults.

Indoor Tanning Association Ends Operations

August 2, 2017 | Categories: News, Policy, Prevention

Statement from the Melanoma Research Foundation

Update on the CURE OM Patient Registry

June 2, 2017 | Categories: News, Ocular Melanoma

“As a patient with choroidal melanoma with metastasis to liver, lymph node and brain, I want to share as much information as possible with other patients, researchers and clinical teams while I still can. They should have access to my story, my history, what has worked for me, what has not worked for me. We need to make headway in finding a cure so the next generation is not asking the same questions we are.

In Faith's Words: Connecting with the OM Community

May 8, 2017 | Categories: Events, Ocular Melanoma, Patient Stories

My name is Faith Hauss and in February of 2015 I was diagnosed with ocular melanoma in my left eye at the age of 42. As compared to other forms of cancer, and even the more common cutaneous (skin) melanoma, the outlook for those with this rare disease can feel devastating to say the least, with as many as of 50% of patients succumbing to the cancer.

Melanoma Awareness Month and a New Look for the MRF

May 1, 2017 | Categories: News

Dear Friends,

Today marks the beginning of Melanoma Awareness Month, a time for our community to come together to educate others and support melanoma survivors and patients. Starting today, you will notice a change to the MRF logo. The MRF board and staff felt that now, our 21st year, was the perfect opportunity to update our logo to better reflect who we are and where we are going as an organization. 

Take Action: Students Need Sunscreen at School

April 19, 2017 | Categories: News, Policy, Prevention

Yesterday, both the Today Show and NBC Nightly News broadcast stories about a disturbing prohibition of sunscreen in schools and the difficulty many parents have in ensuring their child is sun safe during the school day. 

Pages